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While  the pathology  peer  review/pathology  working  group  (PWG)  model  has  long  been used  in  mam-
malian  toxicologic  pathology  to ensure  the accuracy,  consistency,  and  objectivity  of histopathology
data,  application  of  this  paradigm  to  ecotoxicological  studies  has  thus  far been  limited.  In the current
project,  the  PWG  approach  was  used  to evaluate  histopathologic  sections  of gills,  liver, kidney,  and/or
intestines  from  three  previously  published  studies  of  diclofenac  in trout, among  which  there  was  sub-
stantial  variation  in the reported  histopathologic  ﬁndings.  The  main  objectives  of this  review  process
were  to investigate  and  potentially  reconcile  these  interstudy  differences,  and  based  on the results,  to
establish  an  appropriate  no  observed  effect  concentration  (NOEC).  Following  a complete  examination  of
all  histologic  sections  and  original  diagnoses  by a single  experienced  ﬁsh  pathologist  (pathology  peer
review),  a two-day  PWG  session  was  conducted  to allow  members  of a  four-person  expert  panel  to
determine  the  extent  of treatment-related  ﬁndings  in each  of  the three  trout  studies.  The  PWG  was  per-
formed  according  to  the United  States  Environmental  Protection  Agency  (US  EPA)  Pesticide  Regulation
(PR)  94-5  (EPA  Pesticide  Regulation,  1994).  In accordance  with  standard  procedures,  the PWG  review
was  conducted  by  the  non-voting  chairperson  in a manner  intended  to minimize  bias,  and  thus  during
the  evaluation,  the  four  voting  panelists  were  unaware  of  the  treatment  group  status  of individual  ﬁsh
and  the  original  diagnoses  associated  with  the  histologic  sections.  Based  on the  results  of  this  review,
ﬁndings  related  to diclofenac  exposure  included  minimal  to  slightly  increased  thickening  of the  gill ﬁla-
ment  tips  in  ﬁsh  exposed  to the  highest  concentration  tested  (1000 g/L),  plus  a  previously  undiagnosed
ﬁnding,  decreased  hepatic  glycogen,  which  also  occurred  at the 1000  g/L  dose  level.  The panel  found
little  evidence  to support  other  reported  effects  of diclofenac  in  trout,  and  thus  the  overall  NOEC  was
determined  to be  >320  g/L. By  consensus,  the PWG  panel  was  able  to identify  diagnostic  inconsistencies
among  and  within  the three  prior  studies;  therefore  this  exercise  demonstrated  the  value of  the pathol-
ogy  peer  review/PWG  approach  for assessing  the  reliability  of  histopathology  results  that  may  be  used
by  regulatory  agencies  for  risk  assessment.
 201©Abbreviations: DCF, diclofenac; PWG, pathology working group; SP, study
athologist;  RP, reviewing pathologist; NOEC, no observed effect concentration;
OEC,  lowest observed effect concentration.
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1. Introduction
Historically, there have been few toxicological studies in which
organisms were exposed to human or veterinary pharmaceuticals
in surface waters, ground water, and/or sewage sludge (Boxall
et al., 2012; Corcoran et al., 2010). This is particularly true for
investigations of potential chronic toxicity effects. Consequently,
it can be challenging to understand the toxicological and ecological
Open access under CC BY-NC-ND license.importance of drug concentrations measured in the environment.
Although only limited data are available relevant to the ecotox-
icological impact of non-endocrine pharmaceutical ingredients
released into the environment, some reports have suggested that
se.
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Table 1
Summary of experimental designs and reported outcomes from four laboratory studies of diclofenac in trout.
Study Design Diclofenac
conc. tested
(g/L)
n per dose
group
(total n)
Fixation/staining Tissues
examined
Tissues with
exposure
related ﬁndings
No observed
effect
concentration
(NOEC)
Organ with
lowest
observed effect
concentration
(LOEC)
Schwaiger et al.
(2004)
1.8 y rainbow
trout; 28 d
exposure; no
replicate tanks
0, 1, 5, 20, 100,
500
10 (60) Formalin/H&E,
PAS (kidney)
Gills, liver,
kidney, spleen,
intestine
Gills, kidney 1 g/L Gills, kidney
(5 g/L)
Hoeger et al. (2005) 18 m brown
trout; 21 d
exposure; no
replicate tanks
0, 0.5, 5, 50 6 (24) Formalin/H&E;
IHC
(granulocytes,
Thrombocytes,
MHCII)
Gills, liver,
head and trunk
kidney, spleen,
intestine
Gills, liver,
trunk kidney
0.5 g/L Liver (5 g/L)
Mehinto et al.
(2010)
Juvenile (6 w+)
female rainbow
trout; 21 d
exposure; 2
replicate tanks
0, 0.5, 1, 5, 25 10 (50) Bouin’s/H&E Gills, liver,
kidney,
intestine
Kidney,
intestine
0.5 g/L Kidney,
intestine
(1 g/L)
Memmert et al.
(2013)
Juvenile
rainbow trout;
95 d exposure
(33 d prehatch;
62 d
0, 3.2, 10, 32,
100, 320, 1000
20 (140) Davidson’s/H&E;
Azan
Heidenhains
(gills)
Gills, liver,
kidney (whole
ﬁsh sections)
Gills 320 g/L Gills
(1000 g/L)
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replicate tanks
heir presence may  be related to adverse effects in wildlife (Boxall
t al., 2012).
Diclofenac (DCF) is a widely available non-steroidal anti-
nﬂammatory drug (NSAID) that is used to treat a diverse spectrum
f pain and inﬂammatory disorders. Concerns pertaining to possi-
le environmental effects of DCF arose approximately a decade ago
hen initial reports linked the veterinary use of this compound to
ulture population declines in the Indian Subcontinent (Oaks et al.,
004; Shultz et al., 2004). According to these and subsequent arti-
les, a major cause of vulture deaths involved renal damage and
isceral gout that were induced by the birds’ consumption of DCF-
reated livestock carcasses (Oaks et al., 2004; Shultz et al., 2004;
eteyer et al., 2005; Swan et al., 2006).
Diclofenac is regularly detected in sewage treatment plant efﬂu-
nts and surface waters across the globe (Zhang et al., 2008;
ohnson et al., 2013); consequently, a number of studies have
nvestigated the potential for DCF to exert toxicological effects
n aquatic organisms. Included among these are several labora-
ory investigations in which salmonid ﬁshes were exposed to
CF by water bath (Schwaiger et al., 2004; Hoeger et al., 2005;
ehinto et al., 2010; Memmert et al., 2013). Although each of
hese four studies described effects related to diclofenac expo-
ure, histopathologic ﬁndings among the accounts varied in terms
f the organs that were affected, the types of lesions that were
bserved, and the no observed effect concentrations (NOEC) that
ere reported (Table 1). For example, exposure related ﬁndings
ere reported for the gills in three of the four studies (Schwaiger
t al., 2004; Hoeger et al., 2005; Memmert et al., 2013) and for the
idneys in three of the four studies (Schwaiger et al., 2004; Hoeger
t al., 2005; Mehinto et al., 2010). In addition to different ﬁndings
ith respect to the target organs, the studies also differed with
espect to the speciﬁc organ lesions ascribed to DCF exposure in
ach case (Table 2). Exposure related ﬁndings were also reported for
he liver in one study (Hoeger et al., 2005) and for the intestines of
nother study (Mehinto et al., 2010). The NOEC and lowest observed
ffect concentration (LOEC) values varied widely among the three
tudies and were based on histopathologic ﬁndings reported in
ifferent tissues.
It is reasonable to presume that some of this interstudy vari-
bility could be attributed to experimental design differences suchas disparities in ﬁsh species and age, test concentrations, test com-
pound bioavailability, exposure duration, and/or speciﬁc technical
procedures employed for autopsy and histologic slide preparation.
However, because the histopathological assessments were con-
ducted at different laboratories by different individuals, it is also
possible that variation in the results may  have been caused by dif-
ferences in diagnostic interpretation. In order to explore this latter
possibility, a Pathology Working Group (PWG)  was  convened to
review the histologic sections and compare ﬁndings among these
salmonid DCF studies. This independent PWG  panel consisted of
several expert anatomic pathologists who have extensive expe-
rience in the microscopic evaluation of tissues from chemically
exposed ﬁsh.
The pathology peer review and PWG  paradigm (Fig. 1) is
employed routinely to enhance overall quality of histopatho-
logical results produced by toxicological bioassays conducted in
mammals; however, such reviews have had relatively limited
application in ecotoxicological investigations. Brieﬂy, pathology
peer review involves the examination by a second reviewing
pathologist (RP) of histologic slides that were previously evalu-
ated by the initial study pathologist (SP). The primary goal of this
type of review is to improve the accuracy of the histopathologic
evaluation, by ensuring that treatment-related ﬁndings have been
identiﬁed properly, and the severity grading of such ﬁndings has
been scored consistently (Mann and Hardisty, 2013). Peer review
is not the same as a de novo re-evaluation of the study, because
all original diagnoses for each evaluated animal are available to
the RP, who can thereby choose to agree or disagree with each
individual ﬁnding made by the study pathologist; thus, the out-
come of a peer review is intended to be a single data set rather
than two  completely independent sets of data. A peer review may
be conducted prospectively, i.e., prior to ﬁnalization of a study
and/or publication of the results. In such instances, the SP and
the RP may  meet following the peer review to jointly reconcile
diagnostic differences, which often occurs. Alternatively, persisting
interpretive differences between the SP and RP may  be resolved
subsequently by the consensus decisions of a multi-pathologist
PWG  panel. Retrospective peer reviews are generally performed
to address issues involving diagnostic criteria and interpretation
for changes reported in certain target tissues. The results may be
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Table  2
Speciﬁc histopathologic ﬁndings as reported in four laboratory studies of diclofenac in trout.
Gills Liver Kidney Intestine
Schwaiger et al. (2004) 1. Pillar cell necrosis
2. Dilation of capillary walls/telangiectasia
3. Respiratory epithelial cell necrosisa
4. Focal interlamellar cell proliferation (NSb)
5.  Inﬂammation (NS)
6. Epithelial lifting (NS)
No ﬁndings 1. Severe tubular hyaline
droplet degeneration
Interstitial nephritis
No ﬁndings
Hoeger et al. (2005)
(Study 1)
1. Lamellar clubbing
2. Telangiectasis (NS)
3. Hyperplasia (NS)
4. Thickened tips (NS)
5. Mucus cell hyperplasia (NS)
6.  Secondary lamellar fusion (NS)
1. Monocyte inﬁltration
(5 g/L only)
2. Sinusoid distension (NS)
3. Diffuse cytoplasm (NS)
4. Focal necrosis (NS)
5. Basophilic foci (NS)
6. Interstitial proteinaceous
ﬂuid (NS)
7. Scanty cytoplasm (NS)
1. Interstitial
proteinaceous ﬂuid
2. Tubular necrosis
3. Interstitial hyaline
droplets (NS)
4. Proteinaceous casts (NS)
5.  Interstitial and
intravascular
proteinaceous ﬂuid (NS)
No results reported
Mehinto et al., 2010
(Study 2)
Not evaluated No ﬁndings 1. Increased developing
nephrons
2. Tubular necrosis
3. Loss of Bowman’s space
1. Fusion of villi
2. Hyperplasia of villi
3. Increased numbers
and size of goblet cells
(NS)
Memmert et al. (2013)
(Study 3)
1. Focal interlamellar cell proliferation
2. Increased chloride cells
3. Thickened lamellar tips
4. Mononuclear cell foci (NS)
5. Inﬂammation (NS)
6. Angiectasis (NS)
7. Lamellar fusion (NS)
1. Inﬂammatory foci (NS)
2. Enhanced basophilia (NS)
1. Hyaline inclusions (NS)
2. Single cell necrosis (NS)
Not evaluated
u
u
r
c
2
l8. Single cell necrosis of interlamellar cells (NS)
a Bolded ﬁndings were statistically signiﬁcant.
b NS = no signiﬁcant difference between diclofenac exposed trout and controls.
sed for the determination of appropriate NOEC levels, and/or the
se of the results in risk assessment. The usual purpose of a ret-
ospective peer review is to identify potential areas of diagnostic
oncern for further evaluation by a PWG  panel (Mann and Hardisty,
013). In the speciﬁc case of diclofenac, existing trout histopatho-
ogy data has been cited as evidence of a relationship between the
Fig. 1. The peer review/pathology woenvironmental presence of that pharmaceutical and ﬁsh population
declines (European Commission, 2011). Therefore, the reliability of
such data must be substantiated if regulatory agencies are to make
informed decisions.
Selection criteria for the voting PWG  panel members, who
are invited to participate by the non-voting PWG  chairperson,
rking group (PWG) paradigm.
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enerally include advanced experience in toxicologic pathology,
pecial expertise in the area of pathology that is relevant to the
eview, and a lack of conﬂicting interests (Mann and Hardisty,
013). Because they have the most familiarity with the speciﬁc
esion types to be addressed, it is also customary to include SPs
nd RPs in the panel. During their evaluations, the members of this
xpert group are kept unaware of (“blinded” to), the original diag-
oses and treatment group status of individual animals. Further
nformation on the theory and conduct of pathology peer review
nd PWG  can be found in a number of review and best practices doc-
ments (Hardisty and Boorman, 1986; The Society of Toxicologic
athologists, 1991; Ward et al., 1995; The Society of Toxicologic
athologists, 1997; Crissman et al., 2004; Boorman et al., 2010;
ann, 1996; Morton et al., 2010).
The purpose of the present paper is to describe the procedures
sed for this particular DCF trout PWG, report the PWG  ﬁndings,
nd illustrate the importance of microscopic slide review for ensur-
ng the reliability of histopathology data that may  be utilized by
egulatory bodies as criteria for ecotoxicological risk assessment.
. Materials and methods
The original intent of this project was to review material from all
our of the DCF trout studies that were described in the introduc-
ion; however, materials from the (Schwaiger et al., 2004) study
ere not available. Consequently, reviews were limited to slides
nd accompanying data from Hoeger et al. (2005) (designated here
s Study 1), Mehinto et al. (2010) (designated as Study 2), and
emmert et al. (2013) (Study 3). Table 1 provides an overview
f the experimental designs and reported outcomes from the four
CF studies, whereas Table 2 compares the speciﬁc histopathologic
ndings from those studies.
.1. Study 1 materials
All slides and a spreadsheet containing transcribed individual
nimal data were available for Study 1 (the original data sheets from
he pathology evaluation were no longer retrievable). The spread-
heet contained scores for the DCF-exposed ﬁsh but no ﬁndings for
ny control animals. The Study 1 slide set consisted of 24 histologic
lides (1 per ﬁsh) that had been stained with hematoxylin and eosin
H&E). Each slide contained two sections of excised liver, two sec-
ions of excised posterior kidney, and a single section of excised gill
rch with ﬁlaments (primary lamellae).
.2. Study 2 materials
All slides and the published summary data were furnished for
tudy 2, but the individual animal data upon which the publication
as based were no longer available. A total of 297 H&E-stained
lides were on hand from this study. There were three slides (A, B,
nd C) of excised kidney for each of 50 ﬁsh, and three slides (A, B,
nd C) of excised intestine for each of 50 ﬁsh. The animal numbers
or the kidney slide labels did not correlate to those of intestine
lides, so the total number of animals represented could not be
etermined. Each kidney or intestine slide contained two  or three
ibbons of serial sections (approximately 10 to 30 sections total
er slide), and sections from all three slides per ﬁsh (A, B, and C)
ad been cut in series from the same block (thus for each ﬁsh, all
ections of kidney and all sections of intestine were virtually iden-
ical). The kidney sections appeared to have been microtomed in
he longitudinal (axial) plane, and comprised varying proportions
f anterior (hematopoietic) and/or posterior (urinary) kidney. The
ntestine sections had been microtomed transversely, i.e., perpen-
icular to the longitudinal axis of the gut.gy 146 (2014) 127– 136
2.3. Study 3 materials
Because the conduct of Study 3 followed OECD Test Guideline
210 (OECD, 1992), all slides and the entire ﬁnal toxicology report
including individual animal data were provided. A total of 140 H&E-
stained slides were available (1 per ﬁsh). Each slide contained two
parasagittal sections of decalciﬁed whole ﬁsh. Following an initial
assessment, duplicate slides that had been stained with Heiden-
hain’s Azan stain did not appear to provide additional information
and were thus not further examined.
2.4. Pathology peer review of Studies 1–3
Prior to the re-evaluations, the original individual animal data
for Studies 1 and 3 were entered electronically into proprietary
dedicated peer review software (PQA). For Study 2, only the animal
numbers were entered into the PQA software. Peer review of the
initial histopathology ﬁndings from three studies was  performed by
Jeffrey C. Wolf, DVM, DACVP. Dr. Wolf (the RP) examined by light
microscopy all slides that contained one or more of the target tis-
sues (i.e., gills, liver, kidney, and/or intestine), in concert with each
of the original diagnoses recorded by the SP. A combined total of 461
slides were examined for the three studies. These slides contained
>6000 sections, which were associated with 37 different types
of diagnoses. For Study 2, in which the individual animal results
were not available, the RP examined the tissues for the types of
changes that were reported in the published article (Mehinto et al.,
2010). For each of the three studies, the peer review ﬁndings were
recorded into the PQA software. This software allowed the RP to
either agree or disagree with each individual original diagnosis that
had been recorded by the SP. The RP also had the option of provid-
ing an alternate diagnosis for each disagreement. Diagnoses made
by both the SP and RP were retained so that comparisons could be
made in software-generated reports. During the peer review, ﬁnd-
ings were graded progressively for severity according to the scoring
systems that were used in the original studies:
Study 1: no ﬁndings, mild, mild to moderate, moderate, or severe
Study 2: no ﬁndings, mild, moderate, or severe
Study 3: no ﬁndings, minimal, mild, moderate, marked, or severe.
Ultimately, the results of the peer review assessment helped the
PWG chairperson to identify the types of diagnostic differences that
the PWG  panel would need to resolve.
2.5. PWG  review of studies 1–3
The PWG  was  chaired by Jerry F. Hardisty, DVM, DACVP, FIATP,
Experimental Pathology Laboratories, Inc. (EPL®), who  organized
and presented the material to the panel, and served as the author
of the PWG  report following the PWG  review. Voting members of
the independent PWG  panel consisted of four pathologists who
have expertise in the diagnosis of toxicologic effects in ﬁsh tissues,
and these included Helmut Segner, PhD, Christine Ruehl-Fehlert,
DVM, Klaus Weber, DVM, PhD, and Dr. Wolf (the RP). Dr. Weber
was also the SP for Study 3. The two-day PWG  was conducted at
AnaPath GmbH, located in Oberbuchsiten, Switzerland on May  1–2,
2013.
The purpose of the two-day PWG  was  to review H&E-stained
sections of kidney, liver, gills, and/or intestine from each of the three
laboratory studies in trout to characterize spontaneous and poten-
tial exposure-related changes, if any, as they relate to ﬁndings that
were reported by the SP and RP, and to conﬁrm the no observed
effect concentration (NOEC) of diclofenac based on histopatho-
logic ﬁndings. The PWG  was performed according to the United
J.C. Wolf et al. / Aquatic Toxicolo
Table  3
Slide selection criteria for each of the three studies evaluated in the pathology
working group (PWG) review.
Study 1
Liver, kidney and gills from the ﬁrst ﬁve ﬁsh in the control group
Liver, kidney and gills from the ﬁrst ﬁve ﬁsh in the LOEC (5 g/L) dose
group
Liver, kidney and gills from the ﬁrst ﬁve ﬁsh in the NOEC (1 g/L) dose
group
The subset above included slides representing differences of opinion in
diagnosis between the reviewing pathologist’s ﬁndings and the original
ﬁndings reported by the study pathologist
Study 2
Kidney and intestine from the ﬁrst ﬁve ﬁsh in the control group
Kidney and intestine from the ﬁrst ﬁve ﬁsh in the LOEC (1 g/L) dose group
Kidney and intestine from the ﬁrst ﬁve ﬁsh in the NOEC (0.5 g/L) dose
group
Kidney was  examined from additional animals when urinary kidney was
not available from the ﬁrst ﬁve ﬁsh
Because each of the three slides (A–C) for each organ consisted of 10–30
serial sections that were derived from a single parafﬁn block, only slide B
was  examined by the PWG
In order to conﬁrm the incidence of goblet cell proliferation in the highest
dose group (25 g/L), sections of intestine were examined from all control
and  exposed ﬁsh
Study 3
Gills, kidney and liver from the ﬁrst ﬁve ﬁsh in the control group replicate
B  and D
Gills, kidney and liver from the ﬁrst ﬁve ﬁsh in the LOEC (1000 g/L) dose
group from replicates B and D
Gills, kidney and liver from the ﬁrst ﬁve ﬁsh in the NOEC (320 g/L) dose
group from replicates B and D
This included slides representing differences of opinion in diagnosis
between the reviewing pathologist’s ﬁndings and the original ﬁndings
reported by the study pathologist
Following the initial review of the above ﬁsh, all livers from all ﬁsh in each
replicate for the controls, 320 g/L dose group, and 1000 g/L dose group
were examined to determine the distribution of decreased glycogen
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the control group animals. However, there were many instancesamong those groups
tates Environmental Protection Agency (US EPA) Pesticide Regu-
ation (PR) 94-5 (EPA Pesticide Regulation, 1994). At the onset of
he PWG, Dr. Wolf presented an overview of the three studies to be
eviewed, including photomicrographic ﬁgures from the original
ublications. Dr. Hardisty then presented the PWG  approach and
osed speciﬁc questions that were to be addressed by the panelists
ollowing microscopic examination of the slides.
The slides selected for evaluation included representative sec-
ions that were deemed necessary to determine the NOEC for each
tudy and to resolve diagnostic differences between ﬁndings of
he RP and the original diagnoses reported by the SPs. It was the
esponsibility of the PWG  Chairperson to select slides for review
y methods that strive to minimize potential bias, and slide selec-
ion criteria for each of the three studies are presented in Table 3.
abel identiﬁcations on the selected slides were masked and coded
y the non-voting Chairperson. Thus, when these materials were
xamined by the panelists, they had no knowledge of the diclofenac
xposure status or previous ﬁndings associated with individual
lides. This allowed the PWG  to determine the nature of the changes
ithout being inﬂuenced by awareness of the original diagnoses.
ach participant recorded his/her diagnoses and comments on
orksheets that were prepared by the PWG  Chairperson.
At the end of the slide evaluation period, the PWG  data were
ocked (i.e., no further changes to the data were permitted) and tab-
lated, and the results were revealed to the PWG  participants. The
articipants were then asked to characterize the ﬁndings in each
f the examined tissues, and to distinguish between spontaneous
nd exposure related changes. The PWG  panelists were also asked
o determine the NOEC for diclofenac in each of the three stud-
es based on their ﬁndings. After the slides had been examined, thegy 146 (2014) 127– 136 131
ﬁnal PWG  consensus diagnoses were recorded on the Chairperson’s
worksheets. Consensus diagnoses of the PWG  were reached when
the majority of the PWG  participants were in agreement.
After the data were locked (i.e., could no longer be changed)
group-wise differences in lesion prevalence between diclofenac
treated ﬁsh and controls were conﬁrmed using a 2-sided Fisher’s
exact test (Piegorsch and Bailer, 1997), with ﬁndings tested for
signiﬁcance at p ≤ 0.05.
3. Results
The Pathology Working Group (PWG) is considered to be the
arbiter of diagnostic differences between the study and reviewing
pathologist; therefore, for simplicity only the results of the PWG
will be described. These results represent the consensus opinions
of the panel. By the conclusion of the two-day workshop, initial dif-
ferences among the PWG  panelists were resolved to the satisfaction
of all four panel members.
3.1. PWG  results for Study 1
The study pathologist’s (SP’s) original diagnoses for the
gills included lamellar clubbing, hyperplasia (lamellar epithelial
hyperplasia), mucous cell hyperplasia, secondary lamellar fusion,
telangiectasia (angiectasis), and thickened (ﬁlament) tips; origi-
nal diagnoses for the liver included diffuse cytoplasm (decreased
glycogen), focal necrosis, foci of enhanced basophilia, intersti-
tial proteinaceous ﬂuid, monocyte accumulation (mononuclear
cell inﬁltrates), scanty cytoplasm (increased glycogen), and sinu-
soidal distension; and original diagnoses for the posterior kidney
included interstitial hyaline droplets, interstitial proteinaceous
ﬂuid, intraluminal/intratubular proteinaceous ﬂuid, intravascular
proteinaceous ﬂuid, proteinaceous casts, and tubular necrosis. The
overall quality of the histologic sections for Study 1 was judged
by the PWG  participants to vary from good (liver) to fair (kidney
and gill). Kidney sections were often considered to be excessively
thick.
Results of the PWG  evaluation for Study 1 are compared to the
original ﬁndings in Table 4. The most prevalent types of ﬁndings
identiﬁed by the PWG  occurred in the gills and included lamel-
lar clubbing, lamellar epithelial hyperplasia, secondary lamellar
fusion, telangiectasis, and thickened lamellar tips. The most fre-
quent ﬁnding in the liver was the presence of mononuclear cell
inﬁltrates, and in the kidney, interstitial hyaline droplets and inter-
stitial proteinaceous ﬂuid were recorded at the highest frequency.
Regarding these latter two ﬁndings, the PWG  panelists believed
the interstitial hyaline droplets were probably an artifact of the
histologic staining process, whereas the dark pink appearance of
interstitial proteinaceous ﬂuid (most of which actually appeared
to be intravascular) was  likely a function of excessive section
thickness. The overall severity of these ﬁndings varied from mild
to moderate, and none of these ﬁndings was substantially more
prevalent or severe in diclofenac exposed ﬁsh when compared to
unexposed controls.
There were several ﬁndings reported by the SP that were not
observed to any degree by the PWG. For the liver, these included
foci of enhanced basophilia, interstitial proteinaceous ﬂuid, and
sinusoidal distension. For the kidney, types of ﬁndings that were
not conﬁrmed by the PWG  included proteinaceous casts and
tubular necrosis.
The SP’s original data did not report any diagnoses for any ofin which the PWG  panel recorded ﬁndings for that group.
Examples for the gill included lamellar clubbing, lamellar epithe-
lial hyperplasia, secondary lamellar fusion, telangiectasis, and
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Table 4
Prevalence and severity of Study 1 ﬁndings as determined by the study pathologist and the pathology working group (PWG).
Study pathologist PWG
Diclofenac concentration (g/L) 0 0.5 (NOEC) 5 (LOEC) 50 0 0.5 5
na 6 6 6 6 6 6 6
Gills Lamellar clubbing 0b 0 0 4 4 5 2
Mild –c – – 3 4 5 2
Mild–moderate – – – 1 – – –
Lamellar epithelial hyperplasia 0 0 2 2 5 6 6
Mild – – 2 2 4 3 2
Mild–moderate – – – – 1 3 3
Moderate – – – – – – 1
Mucous cell hyperplasia 0 0 1 0 0 1 2
Mild – – 1 – – 1 1
Mild–moderate – – – – – – 1
Secondary lamellar fusion 0 0 1 2 4 4 4
Mild – – – 1 3 4 4
Mild–moderate – – 1 1 1 – –
Telangiectasis 0 5 2 4 2 6 2
Mild – 2 – – 2 3 –
Mild–moderate – – – 3 – – –
Moderate – 2 2 1 – 3 2
Thickened ﬁlament tips 0 0 1 0 5 3 4
Mild – – 1 – 3 2 1
Mild–moderate – – – – 2 1 2
Moderate – – – – – – 1
Liver Decreased glycogen 0 1 2 1 4 2 2
Mild – 1 1 – 1 1 1
Mild–moderate – – 1 1 3 1 1
Focal necrosis 0 0 2 3 0 0 0
Mild – – 1 3 – – –
Mild–moderate – – 1 – – – –
Foci  of enhanced basophilia 0 0 1 1 0 0 0
Mild – – 1 1 – – –
Increased glycogen 0 2 1 0 1 2 1
Mild – 2 1 – 1 2 1
Interstitial proteinaceous ﬂuid 0 0 1 1 0 0 0
Mild – – 1 1 – – –
Mononuclear cell inﬁltrates 0 2 5 4 5 6 5
Mild – 2 2 3 5 5 4
Mild–moderate – – 3 1 – 1 1
Sinusoidal distension 0 1 2 3 0 0 0
Mild – – 2 2 – – –
Mild–moderate – 1 – 1 – – –
Trunk  kidney Interstitial hyaline droplets 0 5 2 3 3 5 2
Mild – 5 2 1 3 4 2
Mild–moderate – – – 2 – 1 –
Interstitial proteinaceous ﬂuid 0 0 3 5 2 3 3
Mild – – 3 2 2 3 3
Mild–moderate – – – 2 – – –
Moderate – – – 1 – – –
Intratubular proteinaceous ﬂuid 0 0 1 1 0 0 1
Mild – – 1 1 – – 1
Intravascular proteinaceous ﬂuid 0 0 0 1 1 0 0
Mild – – – 1 1 – –
Proteinaceous casts 0 0 0 1 0 0 0
Mild – – – 1 – – –
Tubular necrosis 0 0 0 3 0 0 0
Mild–moderate – – – 1 – – –
Moderate – – – 2 – – –
a Number of sections evaluated.
b
t
g
k
i
i
i
i
w
eNumber of animals affected.
c A dash indicates that no animals were affected at that severity grade.
hickened lamellar tips. For the liver, these included increased
lycogen and mononuclear cell inﬁltrates. And for the posterior
idney, diagnoses recorded by the PWG  in control ﬁsh included
nterstitial hyaline droplets, interstitial proteinaceous ﬂuid, and
ntravascular proteinaceous ﬂuid.
Based on the results of the PWG  evaluation, there were no ﬁnd-
ngs for which the prevalence and/or severity was  signiﬁcantly
ncreased in diclofenac-treated ﬁsh relative to controls. Thus, there
ere no exposure related ﬁndings for any of the three tissue types
xamined in Study 1.3.2. PWG  results for Study 2
According to the published results of Study 2, ﬁndings identi-
ﬁed in the kidney included increased developing nephrons, loss of
glomerular Bowman’s space, and tubular necrosis. Findings in the
intestines included fusion of villi (mucosal folds), hyperplasia of
villi, and increased numbers and sizes of goblet cells.
The overall quality of the histologic sections for Study 2 was
judged by the PWG  participants to vary from fair (intestine) to
poor (kidney). The H&E staining had faded substantially in both the
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Table  5
Prevalence and severity of Study 2 ﬁndings as determined by the peer review pathologist and the Pathology Working Group (PWG).
Diclofenac concentration 0 g/L 0.5 g/L (NOEC) 1 g/L (LOEC) 5 g/L 25 g/L
Kidney na 5 5 3 7 7
Developing nephrons 4b 4 3 ndc ndc
Mild 4 4 3
Loss of Bowman’s space 5 5 3 7d 7d
Mild 5 4 3 5 5
Moderate –e 1 – 2 2
Intestine n  9 10 10 8 13
Increased goblet cell size and/or number 3 3 2 2 7
Mild 3 3 2 2 5
Moderate – – – – 2
a Number of renal sections that contained urinary kidney.
b Number of animals affected.
c No diagnoses of increased developing nephrons were recorded by the reviewing pathologist for any ﬁsh, and ﬁsh in this dose group were not evaluated by the PWG.
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e A dash indicates that no animals were affected at that severity grade.
idney and intestine sections, and the kidney sections were exces-
ively thick and had microtomy chatter artifacts. Another issue
elevant to the kidney sections involved the amount of urinary
mesonephric, posterior) kidney that was available for analysis.
lides from 20 of the 50 evaluated ﬁsh contained insufﬁcient
mounts of urinary kidney for diagnostic purposes. This included
0 ﬁsh for which no urinary kidney was available (i.e., sections
onsisted entirely of hematopoietic [anterior] kidney), and 10 ﬁsh
or which only minimal amounts of urinary tissue (e.g., only a few
ubules) were available. Because the original ﬁndings pertained
nly to the urinary elements of the kidney (i.e., glomeruli and
ubules), these 20 ﬁsh were effectively excluded from further eval-
ation. There were eight additional animals for which the amount
f urinary kidney present in the sections was considered subopti-
al; however, diagnoses were recorded by the PWG  for ﬁsh of this
ubset.
Results of the PWG  evaluation for Study 2 are presented in
able 5. The prevalence and severity results recorded by the PWG
annot be compared directly to those of the SP, because the lat-
er data were reported as mean severity scores per dose group
Mehinto et al., 2010).
During the peer review, the reviewing pathologist (RP) had not
ecorded any diagnoses of increased developing nephrons, because
 low number (usually 1–2) of developing nephrons were present
n most of the sections that contained sufﬁcient amounts of urinary
idney, and these structures were not observed to be increased in
ny diclofenac-treated ﬁsh when compared to controls. However,
he PWG  opted to record the presence of developing nephrons as
n absolute (versus relative) ﬁnding, and conﬁrmed that, compared
o controls, there were no increases in the prevalence and sever-
ty of developing nephrons in ﬁsh exposed at the NOEC and LOEC
oncentrations (i.e., 0.5 and 1 g/L diclofenac). The PWG  also did
ot ﬁnd the loss of Bowman’s space to be an exposure related ﬁnd-
ng. Throughout their evaluation, panelists observed that the size
f this microanatomic cavity tended to vary considerably among
lomeruli within the same kidney section, and that glomeruli with
ittle or no apparent Bowman’s space could be visualized in virtu-
lly every examined section of urinary kidney. However, the PWG
id endeavor to evaluate the prevalence and severity of this ﬁnding,
nd the results of that blinded scoring did not provide evidence that
iclofenac exposure was associated with a substantially greater
revalence or severity of collapsed Bowman’s space. Finally, the
WG did not identify any instances of tubular necrosis in any of the
ections that contained urinary kidney (nor was  tubular necrosis
bserved by the RP during the peer review phase).
Concerning the intestines, the PWG  did not ﬁnd any mor-
hologic evidence of fused villi or hyperplasia of villi during
he microscopic review of intestine sections. Based on depictionsWG  did not evaluate this group.
in photomicrographic ﬁgures from the associated publication
(Mehinto et al., 2010), the panelists concluded that these ﬁndings
were plane-of-section artifacts. The mucosal surface of the trout
intestine actually consists of short folds rather than true ﬁnger-
like villi (Dale et al., 2009). Evidence from the photomicrographs
suggested that tangential sectioning across the edges of folds was
responsible for the appearance of mucosal epithelial hypercellular-
ity, whereas oblique sectioning through the broad base of a single
fold created the appearance of two villi that were fused at the
tips. However, the PWG  did observe a tendency for greater preva-
lence and severity of increased goblet cell size and/or number in
the intestines of ﬁsh in the 25 g/L dose group as compared to
controls, although the difference in prevalence was not statisti-
cally signiﬁcant (p = 0.3050). Panelists also questioned whether this
slight variation in goblet cell size/number may  have been a func-
tion of sample collection, as goblet cell numbers are known to vary
progressively along the length of the trout intestine (Anderson and
Mitchum, 1974); Yasutake and Wales, 1983; Khojasteh et al., 2009).
Based on the results of the PWG  evaluation, there were no ﬁnd-
ings for which the prevalence and/or severity was signiﬁcantly
increased in diclofenac-treated ﬁsh relative to controls. Thus, there
were no exposure related ﬁndings for any of the three tissue types
examined in Study 2.
3.3. PWG  results for Study 3
The SP’s original diagnoses for the gills included angiecta-
sis, focal proliferation of interlamellar cells, focal proliferation
of chloride cells, thickened lamellar tips, lamellar fusion, single
cell necrosis of interlamellar cells, inﬂammation, and focal mono-
nuclear cells. Original diagnoses for the liver included inﬂammatory
cell foci and enhanced basophilia, whereas original diagnoses for
the kidney included (single cell) necrosis and the presence of hya-
line deposits/droplets.
The overall quality of the histologic sections for Study 3 was
judged by the PWG  participants to be very good.
Results of the PWG  evaluation for Study 3 are presented in
Table 6. Two ﬁndings that the PWG  identiﬁed as being more
prevalent in the exposure groups than in the control group were
thickened lamellar tips in the gills and decreased glycogen in
the liver. Thickened lamellar tips of the gills were characterized
by broadening of the distal end of the ﬁlaments secondary to
focal epithelial hyperplasia. The severity of thickened lamellar
tips was graded as minimal to mild, and the prevalence of this
ﬁnding was only signiﬁcantly increased at the highest diclofenac
concentration (1000 g/L; p = 0.0457). Decreased glycogen was
diagnosed when there was a generalized reduction in the amount
of translucent space within the cytoplasm of hepatocytes, and both
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Table 6
Prevalence and severity of Study 3 ﬁndings as determined by the study pathologist and the pathology working group (PWG).
Diclofenac concentration (g/L) Study pathologist PWG
0 3.2 10 32 100 320 (NOEC) 1000 (LOEC) 0 320 1000
Gills na 20 20 20 20 20 20 20 20 20 20
Angiectasisb 3c 9 9 9 10 5 11 0 0 0
Minimal 3 5 1 –d 1 – 4 – – –
Slight  – 4 8 5 5 4 4 – – –
Moderate – – – 4 4 1 3 – – –
Focal  proliferation of interlamellar cells/interlamellar cell hyperplasia 10 6 5 9 4 7 13 6 6 6
Minimal 10 5 5 9 4 7 11 6 6 5
Slight  – 1 – – – – 2 – – 1
Focal  proliferation of chloride cells 0 0 0 0 1 0 4 0 1 3
Minimal – – – – 1 – 3 – 1 3
Slight  – – – – – – 1 – – –
Inﬂammation 1 0 0 1 0 0 1 0 0 0
Minimal 1 – – 1 – – 1 – – –
Lamellar epithelial lifting 0 0 0 0 0 0 0 14 16 15
Minimal – – – – – – – 7 10 7
Slight  – – – – – – – 6 5 5
Moderate – – – – – – – 1 1 3
Lamellar fusion 0 0 1 0 0 0 0 0 0 0
Minimal – – 1 – – – – – – –
Mononuclear cells, focal 5 2 6 6 1 2 7 1 0 3
Mild  5 2 6 6 1 2 6 1 – 2
Mild–moderate – – – – – – 1 – – 1
Single  cell necrosis of interlamellar cells 1 0 0 0 0 0 0 1 0 0
Mild  1 – – – – – – 1 – –
Thickened lamellar tips 0 0 0 3 1 0 4 1 1 6*
Minimal – – – 3 1 – 3 1 1 2
Slight  – – – – – – 1 – – 1
Liver n  20 20 20 20 19 20 20 20 20 20
Enhanced Basophilia 0 0 0 0 0 0 1 0 0 0
Minimal – – – – – – 1 – – –
Decreased glycogen 0 0 0 0 0 0 0 2 4 10**
Minimal – – – – – – – 2 4 3
Slight  – – – – – – – – – 1
Marked  – – – – – – – – – 5
Severe  – – – – – – – – – 1
Inﬂammatory cell foci 1 1 2 0 2 3 1 2 3 1
Minimal 1 1 2 – 2 3 1 2 3 1
Kidney n  17 16 20 20 20 19 19 17 19 19
Granular casts 0 0 0 0 0 0 0 0 0 1
Minimal – – – – – – – – – 1
Hyaline  inclusions/droplets 2 4 6 2 2 3 6 7 6 8
Minimal 2 4 6 2 2 3 6 7 6 8
Single  cell necrosis 0 1 2 2 1 0 2 1 1 4
Minimal – 1 2 2 1 – 2 1 1 4
* p ≤ 0.05.
** p ≤ 0.01.
a Number of sections evaluated.
b Original diagnoses of angiectasis were revised to lamellar epithelial lifting by the PWG.
c
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lNumber of animals affected.
d A dash indicates that no animals were affected at that severity grade.
he prevalence and severity of this ﬁnding were increased relative
o controls in the 1000 g/L diclofenac dose group (p = 0.0069).
ther ﬁndings were not substantially more prevalent or severe in
iclofenac exposed ﬁsh relative to controls.
The PWG  observed that initial diagnoses of angiectasis were
ore appropriately categorized as lamellar epithelial lifting,
ecause these changes were characterized by expansion of the
nterstitial space between the lamellar capillary and pavement cell
pithelium, rather than a dilation of the vascular compartment
f the capillaries themselves. The panelists determined that this
nding was unrelated to diclofenac exposure.
Based on the results of the PWG  evaluation, there were two
ndings for which the prevalence and/or severity was signiﬁcantly
ncreased in diclofenac-treated ﬁsh relative to controls. These ﬁnd-
ngs, which occurred in the 1000 g/L diclofenac dose group, were
hickened lamellar tips in the gills, and decreased glycogen in the
iver.4. Discussion
There are a number of reasons why  histopathology is an invalu-
able tool for the identiﬁcation of potential adverse effects in
toxicological bioassays. First, a wide variety of homeostatic dis-
turbances can be observed at the cellular, organ system, and
whole organism levels. Second, unlike many other types of assays,
histopathologic studies can be designed to incorporate a full range
of toxicologic, toxicokinetic, and biotransformative effects. Finally,
histopathology has the ability to furnish mechanistic clues that are
unavailable from other endpoints. However, it is well understood
that the interpretation of morphologic changes in tissue sections
is an inherently subjective exercise. Consequently, pathology peer
review and PWG  procedures were developed to enhance the objec-
tivity of the histopathology endpoint for non-clinical toxicologic
bioassays. Over the past 30 years, this process has been imple-
mented and reﬁned by the National Toxicology Program of the
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ational Institute of Environmental Health Sciences, U.S. Depart-
ent of Health and Human Services (Boorman et al., 2002), and it
as gradually become the industry-wide standard for assuring the
uality of histopathology data (Mann and Hardisty, 2013). Although
pplication of the pathology peer review/PWG model to environ-
ental toxicological studies has thus far been limited, this is not
ntirely without precedence. For example, pathology peer review
as used to conﬁrm histopathologic ﬁndings in an experiment
nvolving the effects of 17 beta-estradiol on Xenopus laevis gonads
Wolf et al., 2010), and the PWG  format was employed to develop
onsensus diagnostic criteria for assessing toxicologically induced
iver lesions in medaka ﬁsh (Boorman et al., 1997).
It is important to distinguish pathology peer review from jour-
al peer review. While it is accepted that journal peer review is
n essential element for improving the overall quality of scientiﬁc
rticles, the ability of journal peer review to conﬁrm the accuracy
f histopathology data is limited, because the actual tissue sec-
ions are never examined as part of that process. Instead, journal
eer review relies on evaluation of printed text descriptions and
ublished photomicrographic ﬁgures, which may  or may  not rep-
esent the complete spectrum of the histopathologic results, and on
he expertise of the journal reviewers, who may  or may  not have
xtensive histopathology experience.
The current project involved an independent blinded review
y several highly experienced toxicologic pathologists of the orig-
nal histologic slides from three studies of diclofenac in trout,
mong which there were substantive differences in the original
istopathologic ﬁndings. This PWG  review identiﬁed key areas of
oncern for each of those three studies. For Study 1, the most toxico-
ogically signiﬁcant issue in the published paper was  the complete
bsence of diagnoses for each of the six control group ﬁsh. This out-
ome by itself was considered unusual, given the fact that many
ypes of ﬁndings diagnosed by the SP (such as lamellar epithe-
ial hyperplasia) would be anticipated to occur to at least some
egree in untreated ﬁsh. Because the original data recording sheets
ere no longer retrievable for Study 1, the lack of recorded ﬁnd-
ngs in control ﬁsh could not be veriﬁed via documentation. Once
he PWG  panel established that ﬁndings such as lamellar clubbing
n the gills and mononuclear cell inﬁltrates in the liver actually
ccurred to a similar extent in both control and diclofenac-exposed
sh, it became clear that the presence of these lesions was entirely
nrelated to diclofenac exposure. The situation for Study 2 was
omewhat different from that of Study 1. In Study 2, the PWG  dis-
greed with several of the SP’s original diagnostic interpretations.
or example, diagnoses of renal tubular necrosis, fusion of intesti-
al villi, and hyperplasia of intestinal villi were not observed to
ny degree by the PWG  panel, whereas the prevalences of other
ndings, such as increased developing nephrons, loss of Bowman’s
pace, and goblet cell size/numbers, were found to be compara-
le in diclofenac exposed ﬁsh and controls. The results of Study 3
ere further different from those of Studies 1 and 2. In Study 3, the
WG identiﬁed decreased hepatic glycogen as a treatment-related
nding that was not previously reported, while conﬁrming the
xistence of another treatment-related ﬁnding: thickened lamel-
ar tips of the gills. These examples demonstrate the value of the
eer review/PWG process, as it is unlikely that any of the aforemen-
ioned issues could have been discovered and assessed by means
ther than through direct slide review.
As a result of the PWG  evaluation, ﬁndings that were found to
e signiﬁcantly more prevalent in diclofenac exposed trout rela-
ive to controls included increased thickened lamellar tips in the
ills and decreased glycogen in the liver in Study 3. Both of these
ndings were only signiﬁcant at the highest concentration tested
1000 g/L). The gill lesions, which were graded as minimal to
light, would not be expected to impact the functionality of the gills
nder normal circumstances, because only the distal segments ofgy 146 (2014) 127– 136 135
the ﬁlaments were affected (Speare and Ferguson, 2006). Due to
the overlapping conformation of the gill arches, the distal tip of the
ﬁlament is the area of the gill that is most exposed to the environ-
ment, and in salmonids, thickening of the ﬁlament tip is thought to
be a non-speciﬁc long-term response to chronic irritation or injury
(Speare and Ferguson, 2006). Similarly, decreased liver glycogen
storage, which is presumed to be reversible, would not necessar-
ily impair survival at the individual or population level. Decreased
hepatic glycogen can be a direct response to toxic insult in some
cases, but often this change is a consequence of negative energy
balance due to treatment-induced inanition or physiological stress
(Wolf and Wolfe, 2005). However, the published account of Study
3 (Memmert et al., 2013) reported no behavioral abnormalities or
signiﬁcant differences in growth among diclofenac-treated trout as
compared to negative control ﬁsh.
Diagnoses of thickened lamellar tips in the gills and decreased
glycogen in the liver were not reported in the study conducted
by Schwaiger et al., 2004 (see Table 2). Conversely, ﬁndings from
Schwaiger et al. (2004) that were not at all evident in the three
trout studies evaluated by the PWG  included pillar cell necrosis and
respiratory epithelial cell necrosis in the gill, and interstitial nephri-
tis in the kidney. Telangiectasis (angiectasis) of the gills, which
refers to aneurysmal dilation of one or more lamellar capillaries,
was reportedly related to diclofenac administration in Schwaiger
et al. (2004); however, this ﬁnding was  observed but was not asso-
ciated with diclofenac exposure in Study 1 (Hoeger et al., 2005),
and was ultimately shown to not be present at all in Study 3
(Memmert at al., 2013), despite the thousand-fold higher top con-
centration of diclofenac used in that study (i.e., 1000 g/L versus
1 g/L). Because telangiectatic lesions tend to resolve via lamellar
thrombosis (Speare and Ferguson, 2006), observations of telang-
iectasis without thrombosis suggest that such changes probably
occurred at some point in the perimortem period, possibly as a con-
sequence of handling during the euthanasia process (Speare and
Ferguson, 2006). Another reported effect of diclofenac administra-
tion in Schwaiger et al. (2004) was severe tubular hyaline droplet
degeneration. Even though hyaline inclusions were observed occa-
sionally as an incidental ﬁnding in renal tubular epithelial cells
of both control and diclofenac-exposed trout Study 3, the sever-
ity of this alteration was  never graded higher than minimal by
either the SP or the PWG  panel. Furthermore, while it is understood
that hyaline droplets in the kidney can be toxicologically induced,
Reimschuessel and Ferguson (2006) noted that it is also possible to
observe numerous hyaline droplets in the proximal renal tubules of
normal ﬁsh as a function of varying husbandry conditions, and thus
they urged caution in the interpretation of that particular ﬁnding.
5. Conclusions
This outcome of this project serves to illustrate the utility of the
peer review/PWG process. Although it was discovered that some
ﬁndings among the three studies were truly different (e.g., the pres-
ence of telangiectasis in Study 1 but not Study 3), potentially as a
function of differing experimental designs, the PWG  revealed that
much of the interstudy variation was  related to issues of diag-
nostic interpretation. The results of the PWG  review were also
instrumental for determining appropriate NOEC levels. Based on
the PWG  ﬁndings, the NOEC for each of the three studies was as
follows: Study 1: 50 g/L (the highest concentration tested); Study
2: 25 g/L (the highest concentration tested); and Study 3: 320 g/L
(the next to highest concentration tested). Consequently, the effec-
tive overall NOEC for diclofenac based on the three studies analyzed
by the PWG  was 320 g/L.
The potential toxicological and ecological impacts of a test
substance cannot be determined by the results of a single
endpoint. Histopathology is most effective when integrated
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ith other in-vivo and in-vitro methodological approaches (e.g.,
ltrastructural, morphometric, molecular, chemical, biochemical,
hysiological, and/or epidemiological investigations). However,
hichever approach is chosen to address a speciﬁc scientiﬁc ques-
ion, it is vital to demonstrate that the results produced by each
ndividual assay are accurate and reliable.
The peer review/PWG paradigm provides a transparent, efﬁ-
ient, and effective method for assuring the accuracy, consistency,
nd objectivity of histopathology ﬁndings. While this model has
ecome standard practice in mammalian toxicologic pathology, to
ate pathology peer review has been underutilized in ecotoxico-
ogical research. However, this situation is anticipated to change
s concern about environmental issues continues to increase, and
he need for objective scientiﬁc data becomes more apparent.
nce environmental scientists become more familiar with the peer
eview/PWG approach, it will be recognized that investigators who
re willing to subject their results to this degree of scrutiny display
he highest levels of professionalism and scientiﬁc integrity. More
mportantly, it will become evident that conﬁdence in reliability of
he data, as inspired by the pathology peer review/PWG process,
s of vital consequence to regulatory agencies as they endeavor to
ncorporate study results in a weight-of-evidence approach to risk
ssessment.
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